Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
about
In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.Synchrotron X-Ray Fluorescence Nanoprobe Reveals Target Sites for Organo-Osmium Complex in Human Ovarian Cancer Cells.Halide Control of N,N-Coordination versus N,C-Cyclometalation and Stereospecific Phenyl Ring Deuteration of Osmium(II) p-Cymene Phenylazobenzothiazole Complexes.Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.Catalytic Metallodrugs: Substrate-Selective Metal Catalysts as Therapeutics.In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance
P2860
Q33626165-0FC23F3A-BA47-4DBF-9B8A-3ED6C62D72E0Q39067087-B6A7A743-A346-4264-B6E6-5444E8BFB670Q46237975-03F16302-C20D-42E2-8B97-5F90739D6080Q46262834-FA1D45BD-1F49-43BB-B582-40E5271A2A1DQ46271057-3B7CE51A-F605-4956-928D-B9000CEE7A0BQ48157762-5A0FB71E-4BFC-4E69-B352-8DF931FD6B97Q56982978-16D54FD6-F766-425B-B5EA-025BC945E90E
P2860
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@ast
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@en
type
label
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@ast
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@en
prefLabel
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@ast
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@en
P2860
P1476
Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation.
@en
P2093
Magdalena Mos
Peter J Sadler
P2860
P304
P356
10.1021/ACS.JMEDCHEM.5B00655
P407
P577
2015-09-23T00:00:00Z